Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.60 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | MITF | O75030 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12952147 | 1.00 | CYP19A1 (0.60) | CYP19A1EPHX1ALDH1A1TSHRMAPT | |
| SCHEMBL27837558 | 1.00 | CYP19A1 (0.60) | CYP19A1EPHX1ALDH1A1TSHRMAPT | |
| SCHEMBL18596846 | 1.00 | CYP19A1 (0.60) | CYP19A1EPHX1ALDH1A1TSHRMAPT | |
| SCHEMBL10171231 | 1.00 | CYP19A1 (0.60) | CYP19A1EPHX1ALDH1A1TSHRMAPT | |
| SCHEMBL12952148 | 1.00 | CYP19A1 (0.60) | CYP19A1EPHX1ALDH1A1TSHRMAPT | |
| SCHEMBL18969092 | 1.00 | CYP19A1 (0.60) | CYP19A1EPHX1ALDH1A1TSHRMAPT | |
| SCHEMBL10171230 | 1.00 | CYP19A1 (0.60) | CYP19A1EPHX1ALDH1A1TSHRMAPT | |
| Hydrochloric Acid SCHEMBL28867274 | 0.98 | CYP19A1 (0.59) | CYP19A1EPHX1ALDH1A1TSHRMAPT | |
| SCHEMBL23255563 | 0.89 | CYP19A1 (0.61) | CYP19A1EPHX1ALDH1A1TSHRMAPT | |
| SCHEMBL3424391 | 0.89 | CYP19A1 (0.61) | CYP19A1EPHX1ALDH1A1TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 444 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514798-B2 | Use of [6]-paradol for stabilization of cosmetic compositions | SYMRISE AG (DE) | 2026-01-06 | — | — | US | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-20220273595-A1 | COMPOSITIONS AND METHODS FOR TREATING ECZEMA | DERMALA, INC. (US) | 2022-09-01 | — | — | US | claimed |
| EP-3010555-B1 | ABSORBENT ARTICLE COMPRISING COMPLEXED OR ENCAPSULATED REACTIVE COMPOUNDS | PROCTER & GAMBLE (US) | 2020-07-15 | — | — | EP | claimed |
| CN-110327483-A | Absorbent article comprising compound or encapsulating reactive compound | 宝洁公司 | 2019-10-15 | — | — | CN | claimed |
| EP-2793790-B1 | ABSORBENT ARTICLE COMPRISING A FRAGRANCE OR ODOR CONTROL COMPOSITION | PROCTER & GAMBLE (US) | 2019-10-02 | — | — | EP | claimed |
| US-20190290605-A1 | COMPOSITIONS AND METHODS FOR TREATING ECZEMA | DERMALA INC (US) | 2019-09-26 | — | — | US | claimed |
| US-20170304486-A1 | ABSORBENT ARTICLE COMPRISING COMPLEXED OR ENCAPSULATED REACTIVE COMPOUNDS | PROCTER & GAMBLE (US) | 2017-10-26 | — | — | US | claimed |
| US-9731042-B2 | Absorbent article comprising complexed or encapsulated reactive compounds | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-15 | — | — | US | claimed |
| CN-103260657-B | Comprise the absorbent article of cyclodextrin complexes | 宝洁公司 | 2016-07-13 | — | — | CN | claimed |
| WO-2012088231-A1 | ABSORBENT ARTICLE COMPRISING CYCLODEXTRIN COMPLEX | THE PROCTER & GAMBLE COMPANY (US) | 2012-06-28 | — | — | WO | claimed |
| EP-2468309-A1 | Absorbent article having releasable odor control | The Procter & Gamble Company (US) | 2012-06-27 | — | — | EP | claimed |
| CN-100522127-C | Perfume composition | KAO CORP (JP) | 2009-08-05 | — | — | CN | claimed |
| CN-101325981-A | Absorbent product | SCA HYGIENE PROD AB (SE) | 2008-12-17 | — | — | CN | claimed |
| US-20030068295-A1 | Odor neutralizers | SYMRISE AG (DE) | 2003-04-10 | — | — | US | claimed |
| US-20030036489-A1 | Consumable composition comprising perfumed particles and article containing the same | THE PROCTER & GAMBLE COMPANY | 2003-02-20 | — | — | US | claimed |
| WO-2002090479-A1 | PERFUMED PARTICLES AND ARTICLES CONTAINING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| WO-2002090481-A1 | COMPOSITIONS AND ARTICLES FOR EFFECTIVE DEPOSITION OF PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| EP-1239890-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2002-09-18 | — | — | EP | claimed |
| WO-2001043784-A2 | ODOR NEUTRALIZERS | HAARMANN & REIMER GMBH (DE) | 2001-06-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030068295-A1 | Odor neutralizers | OXER1, OR51E2, OR10J3 | CYP19A1 444/4885EPHX1 701/4885ALDH1A1 581/4885 |
| US-20220273595-A1 | COMPOSITIONS AND METHODS FOR TREATING ECZEMA | CUTA, PEF1, ELOVL6 | CYP19A1 122/4885EPHX1 151/4885ALDH1A1 3801/4885 |
| US-20190290605-A1 | COMPOSITIONS AND METHODS FOR TREATING ECZEMA | CUTA, PEF1, ELOVL6 | CYP19A1 122/4885EPHX1 151/4885ALDH1A1 3801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.